Soleus Capital Management, L.P. Annexon, Inc. Transaction History

Soleus Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$4.03 - $7.81 $898,690 - $1.74 Million	-223,000 Reduced 43.27%	292,400 $2.1 Million
Q3 2023 Nov 14, 2023	SELL	$2.13 - $3.84 $223,650 - $403,200	-105,000 Reduced 16.92%	515,400 $1.22 Million
Q2 2023 Aug 14, 2023	SELL	$2.1 - $6.37 $619,500 - $1.88 Million	-295,000 Reduced 32.23%	620,400 $2.18 Million
Q1 2023 May 15, 2023	BUY	$3.74 - $7.46 $3.42 Million - $6.83 Million	915,400 New	915,400 $3.52 Million

158

101M

3.61M

1.08M

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $332M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.